GE Amersham Pharmacia AKTA Purifier 10 HPLC System Variable Flow Rate 1 mL/min to 10 mL/min
Baker
Details
-
CategoryHood
-
Dimension31.0in x 65.0in x 85.0in
-
Serial99157
-
Shipping TypeFreight
-
Manufacturing2009-08-31
-
Voltage / Hertz115V / 60Hz US
Description
The GE Amersham Pharmacia AKTA Purifier 10, manufactured in 2005, is a robust High Performance Liquid Chromatography (HPLC) system ideal for purification and separation tasks in biomedical research. This used unit features a variable flow rate ranging from 1 mL/min to 10 mL/min, providing precision and flexibility for various analytical applications. The system is intact with minor signs of prior use, and it includes essential components such as UV detectors but does not come with computer or additional software. Researchers seeking reliable chromatographic performance will find the AKTA Purifier 10 suitable for peptide mapping, mass spec, and high-resolution separations.
Technician comment
SG503A-HE was tested and verified to be in proper working condition. The UV, lights, and blower are all functioning as intended. This unit is preowned from a laboratory environment and shows minor cosmetic wear consistent with normal use. See photos for details.
Key Features
- Variable flow rate: 1 mL/min to 10 mL/min
- Suitable for high-resolution separations
- Accommodates UV detectors
- Robust purification system for peptide mapping
Specifications
- Variable Flow Rate: 1 mL/min to 10 mL/min
- Year of Manufacture: 2005
- Includes UV detectors
- Usage: Ideal for peptide mapping and mass spec applications
- Condition: Used, with minor cosmetic wear
Weight
Imperial: 840.0 Pounds
Metric: 381.02 Kilograms
Shipping Dimensions
Imperial: 37.2 lb x 78.0 lb x 102.0 lb
Metric: 94.49 cm x 198.12 cm x 259.08 cm
Harmonized Code
90279050
Harmonized Code Details
90279050 - Parts and accessories of instruments and apparatus for measuring or checking fluid flow. This code is appropriate as the item is an HPLC system used for measuring fluid separation and purification.
Comments 0
There are currently no public comments.